AllAnalyst Report
logoMorningstarSeptember 16, 2020

DaVita Inc.: DaVita Remains an Essential Business in Any Environment

Symbols
DVA
Sector(s)
Healthcare
Rating
Premium
Current Price
$109.60
Fair Value
Premium
Economic Moat
Premium
Stewardship
Premium
Summary

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates about 3,000 facilities worldwide, mostly in the U.S., and treats over 235,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE